Shanghai Pharmaceuticals Holding Co's market cap is currently $8.06B. The company's EPS TTM is $0.15; its P/E ratio is 7.89; and it has a dividend yield of 5.68%. Shanghai Pharmaceuticals Holding Co is scheduled to report earnings on March 28, 2025, and the estimated EPS forecast is $0.02. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	¥ 260.30B	¥ 231.98B	¥ 215.82B	¥ 191.91B	¥ 186.57B
Gross Profit	¥ 30.93B	¥ 30.49B	¥ 28.54B	¥ 27.44B	¥ 26.81B
Operating Income	¥ 7.67B	¥ 9.01B	¥ 8.21B	¥ 7.18B	¥ 8.93B
EBITDA	¥ 10.90B	¥ 12.44B	¥ 10.55B	¥ 10.44B	¥ 9.35B
Net Income	¥ 3.77B	¥ 5.62B	¥ 5.09B	¥ 4.50B	¥ 4.08B
Balance Sheet
Cash & Short-Term Investments	¥ 40.67B	¥ 37.01B	¥ 22.39B	¥ 22.30B	¥ 18.15B
Total Assets	¥ 211.97B	¥ 198.13B	¥ 163.44B	¥ 149.19B	¥ 137.03B
Total Debt	¥ 42.90B	¥ 38.56B	¥ 31.69B	¥ 31.79B	¥ 34.62B
Net Debt	¥ 12.38B	¥ 11.16B	¥ 9.30B	¥ 9.50B	¥ 16.46B
Total Liabilities	¥ 131.65B	¥ 120.13B	¥ 104.37B	¥ 94.44B	¥ 87.64B
Stockholders' Equity	¥ 68.52B	¥ 67.06B	¥ 49.36B	¥ 45.35B	¥ 41.66B
Cash Flow
Free Cash Flow	¥ 2.26B	¥ 2.06B	¥ 942.55M	¥ 3.83B	¥ 3.27B
Operating Cash Flow	¥ 5.23B	¥ 4.74B	¥ 5.06B	¥ 6.84B	¥ 6.02B
Investing Cash Flow	¥ -2.49B	-	-	-	-
Financing Cash Flow	¥ 231.85M	¥ 12.14B	¥ 1.57B	-	¥ -2.33B

Currency in CNY

Shanghai Pharmaceuticals Holding Co Earnings and Revenue History

Income Statement >

Shanghai Pharmaceuticals Holding Co Debt to Assets

Balance Sheet >

Shanghai Pharmaceuticals Holding Co Cash Flow

Cash Flow >

Shanghai Pharmaceuticals Holding Co Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing